These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7231526

  • 1. Neurotensin blocks certain amphetamine-induced behaviours.
    Ervin GN, Birkemo LS, Nemeroff CB, Prange AJ.
    Nature; 1981 May 07; 291(5810):73-6. PubMed ID: 7231526
    [Abstract] [Full Text] [Related]

  • 2. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW, Nemeroff CB, Prange AJ.
    Neuroscience; 1984 Apr 07; 11(4):919-30. PubMed ID: 6738859
    [Abstract] [Full Text] [Related]

  • 3. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist.
    Jolicoeur FB, Rivest R, St-Pierre S, Gagné MA, Dumais M.
    Neuropeptides; 1985 Apr 07; 6(2):143-56. PubMed ID: 2987745
    [Abstract] [Full Text] [Related]

  • 4. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.
    Carr GD, White NM.
    Life Sci; 1983 Dec 19; 33(25):2551-7. PubMed ID: 6645814
    [Abstract] [Full Text] [Related]

  • 5. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
    Ervin GN, Nemeroff CB.
    Neuropsychopharmacology; 1988 Sep 19; 1(3):243-50. PubMed ID: 3150806
    [Abstract] [Full Text] [Related]

  • 6. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW, Richardson-Carlson R, Duffy P.
    J Pharmacol Exp Ther; 1986 Sep 19; 238(3):1126-31. PubMed ID: 3755755
    [Abstract] [Full Text] [Related]

  • 7. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A, Minogianis EA, Bouchard C, Bédard AM, Lévesque D, Rompré PP, Samaha AN.
    Neuropharmacology; 2017 Sep 01; 123():10-21. PubMed ID: 28522313
    [Abstract] [Full Text] [Related]

  • 8. Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area.
    Kelley AE, Delfs JM.
    Psychopharmacology (Berl); 1991 Sep 01; 103(2):197-203. PubMed ID: 1709289
    [Abstract] [Full Text] [Related]

  • 9. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat.
    Robledo P, Maldonado R, Koob GF.
    Brain Res; 1993 Sep 17; 622(1-2):105-12. PubMed ID: 8242350
    [Abstract] [Full Text] [Related]

  • 10. gamma-Endorphin and N alpha-acetyl-gamma-endorphin interfere with distinct dopaminergic systems in the nucleus accumbens via opioid and non-opioid mechanisms.
    van Ree JM, Gaffori O, Kiraly I.
    Life Sci; 1984 Apr 02; 34(14):1317-24. PubMed ID: 6200747
    [Abstract] [Full Text] [Related]

  • 11. Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus.
    Heal DJ, Green AR.
    Neuropharmacology; 1979 Jan 02; 18(1):23-31. PubMed ID: 105304
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens.
    Blaha CD, Phillips AG.
    Neuroscience; 1992 Aug 02; 49(4):867-77. PubMed ID: 1436486
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 02; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 14. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW, Roberts DC, Koob GF.
    J Pharmacol Exp Ther; 1983 Mar 02; 224(3):662-73. PubMed ID: 6402587
    [Abstract] [Full Text] [Related]

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 02; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 16. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.
    O'Neill KA, Carelli RM, Jarvis MF, Liebman JM.
    Pharmacol Biochem Behav; 1989 Dec 02; 34(4):739-45. PubMed ID: 2560212
    [Abstract] [Full Text] [Related]

  • 17. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP, Marsden CA.
    Brain Res; 1990 Nov 26; 534(1-2):243-50. PubMed ID: 2073584
    [Abstract] [Full Text] [Related]

  • 18. Folate induced-hypermotility response after bilateral injection into the nucleus accumbens of the rat. Possible mediation through dopaminergic mechanisms.
    Stephens RL, Uretsky NJ.
    Neuropharmacology; 1986 Aug 26; 25(8):887-96. PubMed ID: 3022181
    [Abstract] [Full Text] [Related]

  • 19. Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.
    Kelly PH, Moore KE.
    Psychopharmacology (Berl); 1977 Nov 24; 55(1):35-41. PubMed ID: 414259
    [Abstract] [Full Text] [Related]

  • 20. Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.
    Makanjuola RO, Dow RC, Ashcroft GW.
    Psychopharmacology (Berl); 1980 Nov 24; 71(3):227-35. PubMed ID: 6109349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.